MedPath
Found 6 clinical trials|View Analysis
Sort by:

Therapeutic Drug Use for CKD Patients

First Posted Date
2023-04-19
Last Posted Date
2024-04-03
Lead Sponsor
Qianfoshan Hospital
Target Recruit Count
10000
Registration Number
NCT05818995
Locations
🇨🇳

Xiao Li,MD, Jinan, Shandong, China

Different β -Blockers in STEMI and Primary PCI

Not Applicable
Not yet recruiting
Conditions
Primary PCI
Interventions
Drug: β -Blockers
First Posted Date
2020-01-09
Last Posted Date
2020-01-09
Lead Sponsor
Qilu Hospital of Shandong University
Target Recruit Count
1200
Registration Number
NCT04221919

β-blockers Withdrawal in Patients With HFpEF and Chronotropic Incompetence: Effect on Functional Capacity (Preserve-HR)

Phase 4
Completed
Conditions
Heart Failure With Normal Ejection Fraction
Chronotropic Incompetence
Interventions
Drug: Controlled withdrawal of beta-blockers
Diagnostic Test: Cardiopulmonary Exercise Testing
First Posted Date
2019-03-12
Last Posted Date
2021-03-02
Lead Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Target Recruit Count
52
Registration Number
NCT03871803
Locations
🇪🇸

INCLIVA, Valencia, Spain

Coreg and HSRs-Updated Analysis

Completed
Conditions
Hypersensitivity
Interventions
Drug: Carvedilol immediate release only
Drug: Carvedilol extended release only
Drug: Long acting β-blockers
Drug: Other α1/β-adrenergic antagonists
Drug: Short acting Non-selective β-blockers and short acting β1-Selective agents
Other: No β-blocker
First Posted Date
2011-03-16
Last Posted Date
2015-04-15
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
1
Registration Number
NCT01316952

Effects of Cardioselective β-blockers on Dynamic Hyperinflation in COPD

Not Applicable
Completed
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Drug: Bisoprolol
Drug: Placebo
First Posted Date
2011-01-10
Last Posted Date
2011-06-23
Lead Sponsor
Laval University
Target Recruit Count
27
Registration Number
NCT01273298
Locations
🇨🇦

Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Québec, Quebec, Canada

Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients

Phase 4
Completed
Conditions
Cardiovascular Disease
Interventions
Drug: Angiotensin receptor blockers
Drug: β-blockers
Drug: thiazide diuretics
First Posted Date
2005-08-26
Last Posted Date
2012-02-22
Lead Sponsor
Seiji Umemoto, M.D., Ph.D.
Target Recruit Count
3501
Registration Number
NCT00135551
Locations
🇯🇵

Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan

© Copyright 2025. All Rights Reserved by MedPath